Advanced Search
Contact | Corporate | Help

Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Patients With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy

Sponsors:
  • Eli Lilly and Company
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Non-small Cell Lung Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: enzastaurin
  • Drug: pemetrexed
  • Drug: carboplatin
  • Drug: bevacizumab
  • Drug: Placebo
Enrollment:
40

Additional information about NCT00533429.


SourceSolution © 2008-2012